What Should I Do About My Pain?
Question by : what should i do about my pain?
I already posted the back story about my back and hip pain but today it seems to be worse. Everybody is telling me that its not a big deal and to suck it up but I cant even sit down without my back and hip hurting. My parents want me to go to Nashville tomorrow which is 2 and a half hours away. I can’t even sit 5 minutes without hurting. All the dr tells me is take your medicine which only make me go to sleep. Please give me advice on what I should do.
I am taking Lortab Tizanidine and Skelaxin.
Best answer:
Answer by ChiMom
From reading your other post I see that you have had xrays, an MRI, etc and nothing was found.
Muscle spasms may be causing the pain. Also someone suggested bursitis, and here is a link with articles on bursitis;
http://www.google.com/search?q=bursitis+hip+treatment&sourceid=ie7&rls=com.microsoft:en-US&ie=utf8&oe=utf8&rlz=
You posted about your age and weight–As we get older, things can affect us (cause pain) that didn’t beforehand.
this may have been building up for months/years and has now just started causing you pain.
Of course losing weight may help.
I don’t know what medication you are taking or how much.
Are you on flexeril? it is for back pain–muscle spasms. it can make you very drowsy.
Have you tried heat–such as a heating pad or hot water bottle?
i hope yopu are able to get some relief.
What do you think? Answer below!
Man killed in Huntington Beach apartment ID'd
Filed under: Drug Treatment Help Nashville
Records also show that Sledge had a history of drug offenses and was on probation for possession of a controlled substance at the time of his death. According to the Register of Addiction Specialists' website, he was also working toward becoming a …
Read more on OCRegister (subscription)
Karyopharm Therapeutics Announces Data Presentations at American Society of …
Filed under: Drug Treatment Help Nashville
NATICK, Mass., Nov 08, 2013 (GLOBE NEWSWIRE via COMTEX) — Karyopharm Therapeutics Inc. (NASDAQ:KPTI) , a clinical-stage pharmaceutical company focused on discovery and development of novel first-in-class drugs directed against nuclear …
Read more on MarketWatch